BRIEF published on 05/06/2025 at 18:05, 6 months 29 days ago ACTIA Group: Update of Voting Rights as of April 30, 2025 Share Capital Voting Rights Euronext Growth ACTIA Group Toulouse
BRIEF published on 04/25/2025 at 18:05, 7 months 9 days ago ACTIA Group publishes its 2024 Annual Report Investors Dividend Annual Report General Assembly ACTIA Group
BRIEF published on 04/02/2025 at 18:05, 8 months 2 days ago ACTIA Group: voting rights as of March 31, 2025 Share Capital Voting Rights Euronext Growth ACTIA Participation Thresholds
BRIEF published on 03/28/2025 at 18:05, 8 months 7 days ago ACTIA Group: Total Number of Voting Rights and Shares as of February 28, 2025 Share Capital Voting Rights Treasury Shares Euronext Growth ACTIA Group
BRIEF published on 03/28/2025 at 07:05, 8 months 8 days ago ACTIA Group: 2024 Financial Results Innovation Financial Results Growth Mobility ACTIA Group
Published on 12/05/2025 at 02:35, 5 hours 14 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 49 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 44 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 49 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 49 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 19 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 58 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 24 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 34 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 49 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 4 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 14 hours 5 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
